Teva Pharmaceutical Industries (TEVA) EBT Margin (2016 - 2026)
Teva Pharmaceutical Industries (TEVA) posted EBT Margin of 10.97% for Q1 2026, up 546.25% on a QoQ basis from 1.7% in Q4 2025, and up 342.0% year-over-year from 2.48% in Q1 2025.
Teva Pharmaceutical Industries (TEVA) EBT Margin (2016 - 2026) Analysis & Trends
Teva Pharmaceutical Industries' EBT Margin history runs 11 years deep, the most recent figure standing at 10.97% for Q1 2026.
- Quarterly EBT Margin rose 342.0% year-over-year to 10.97% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.87% (up 1129.0% YoY) and the FY2025 annual result came in at 7.09%, up 1485.0% from the prior year.
- EBT Margin was 10.97% for Q1 2026 at Teva Pharmaceutical Industries, up from 1.7% in the prior quarter.
- Across five years, EBT Margin topped out at 14.42% in Q3 2025 and bottomed at 39.38% in Q4 2023.
- A 5-year average of 7.21% and a median of 5.91% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin slumped 3899 bps — and 2024, when it jumped 3086 bps.
- Teva Pharmaceutical Industries' EBT Margin stood at 30.51% in 2022, then retreated by 29 bps to 39.38% in 2023, then soared by 78 bps to 8.52% in 2024, then jumped by 120 bps to 1.7% in 2025, then jumped by 546 bps to 10.97% in 2026.
- Business Quant data shows TEVA's EBT Margin at 10.97% in Q1 2026, 1.7% in Q4 2025, and 14.42% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 40.73% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 6.35% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -3.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.97% |
| Dec 31, 2025 | 1.70% |
| Sep 30, 2025 | 14.42% |
| Jun 30, 2025 | 4.86% |
| Mar 31, 2025 | 7.56% |
| Dec 31, 2024 | -8.52% |
| Sep 30, 2024 | -7.48% |
| Jun 30, 2024 | -5.91% |
| Mar 31, 2024 | 12.23% |
| Dec 31, 2023 | -39.38% |
| Sep 30, 2023 | 1.66% |
| Jun 30, 2023 | -23.80% |
| Mar 31, 2023 | -7.43% |
| Dec 31, 2022 | -30.51% |
| Sep 30, 2022 | 4.76% |
| Jun 30, 2022 | -31.11% |
| Mar 31, 2022 | -26.52% |
| Dec 31, 2021 | -4.27% |
| Sep 30, 2021 | 9.83% |
| Jun 30, 2021 | 7.88% |